Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Míreanna comhchosúla

• Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
  de réir: Mighiu, AS, et al.
  Foilsithe / Cruthaithe: (2021)
• Role of diabetes mellitus in atrial fibrillation and potential new treatments
  de réir: Ziberna, K
  Foilsithe / Cruthaithe: (2020)
• 154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
  de réir: Mighiu, A, et al.
  Foilsithe / Cruthaithe: (2017)
• Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
  de réir: Simon, J, et al.
  Foilsithe / Cruthaithe: (2016)
• BH4 supplementation as a new treatment for diabetic cardiomyopathy
  de réir: Carnicer, R, et al.
  Foilsithe / Cruthaithe: (2019)